Skip to content

DRTS - Alpha Tau Medical Ltd. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchD

Alpha Tau Medical Ltd

DRTS · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

D

DRTSAlpha Tau Medical Ltd

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $14.75
52-wk low: $3.06
Prev close: $9.80
Mkt cap: $1.32B
Beta: 1.19
P/B: 29.8x

Smart money

7 funds hold a position.

Real smart money

Funds holding this stock

7 holders

Combined position$5.0M

CW
Cathie Wood
Q2 2026 13F
$3.5M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in $0.36 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.3B

Valuation

P/B29.75

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: DRTS
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.32B
Beta: 1.19

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-141.7%

$774K

position

SQ

Squarepoint

Q2 2026 13F

$260K

position

4 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 4 holders

Coverage gaps for DRTS

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.50-$0.36

-$0.14 expected

Next report

What the street expects next

EPS expected

-$0.13

-$0.13 to -$0.13

Revenue expected

$491.0K

3 analysts

Last 30 days

1up3down

Analysts cutting estimates

Estimate drift

+0.01

Change in 30 days

-141.7%

ROA-25.7%

Growth

Beta1.19